Qiagen opens €13 million hub near Barcelona; Kadans tops out London labs

Qiagen opens €13 million innovation centre in Spain.
In:

Good morning,

We have 10 deals this week, taking in Qiagen's €13 million global innovation centre near Barcelona and the topping-out of One North Quay, a 570,000 sq ft science campus at Canary Wharf. Let's dive in.

In today's free edition:
🇪🇸 Qiagen opens €13 million innovation centre in Catalonia
🇬🇧 One North Quay science campus tops out in London

🔒 For paying members only:
🇬🇧 Healthcare joint venture raises target to £400 million
🇩🇪 Fund buys large health centre in Baden-Württemberg
🇮🇪 Leinster office building secures medical-use permission
🇬🇧 Preclinical CRO adds radiometric labs in West Midlands
🇬🇧 £200 million inhaler manufacturing boost in East Midlands
🇬🇧 Large research building approved in Oxfordshire
🇱🇹 Supplement maker starts building lab in Vilnius County
🇬🇧 Grant backs £500 million North West R&D hub

Subscribe here to unlock.

Enjoy today's newsletter,

Stephen Ryan


🇪🇸 Qiagen opens €13 million global innovation centre near Barcelona

Esplugues de Llobregat in greater Barcelona (source: espluguescampus.com)

Qiagen has opened an 8,000 sq m global innovation centre in Esplugues de Llobregat, near Barcelona, following a €13 million investment over two years.

Located on the Esplugues Campus at the former Braun factory, the facility brings together research and development, manufacturing and supporting functions for Qiagen's QIAstat-Dx molecular diagnostics platform.


🇬🇧 One North Quay science campus tops out at Canary Wharf

One North Quay (source: onenorthquay.com)

One North Quay, a 23-storey science, technology and innovation campus at Canary Wharf, has topped out.

Developed by CWG (jointly owned by Brookfield and the Qatar Investment Authority) and Kadans Science Partner, the building will provide 570,000 sq ft of workspace and laboratory space for businesses at every growth stage.

The scheme, designed by KPF as a vertical campus, sits next to the Elizabeth line station.

Completion is due in early 2028.

Written by
Stephen Ryan
Stephen is an independent real estate researcher and CFA charterholder who founded Life Sciences Real Estate in 2022.

Stay on top of the life sciences real estate markets in Europe

Join us
Great! You’ve successfully signed up.
Welcome back! You've successfully signed in.
You've successfully subscribed to Life Sciences Real Estate.
Your link has expired.
Success! Check your email for magic link to sign-in.
Success! Your billing info has been updated.
Your billing was not updated.